JEFFS ROGER

Average Profitability
9.17%
Insider Buys Quantity
7
Insider Buys Sum
$2.1M
Insider Sells Quantity
281
Insider Sells Sum
$177.75M

Insider Activity of JEFFS ROGER

According to the SEC Form 4 filings, JEFFS ROGER, being in a position of

  1. Chief Executive Officer at Liquidia Corporation,
    оver the last 12 months, has bought 0 shares, and sold 46809 shares for $575,444,
    over all time since 2021-04-13, has bought 410890 shares for $1.85M, and sold 75392 shares for $1.03M.

The largest purchase of all time was on 2023-12-14 and amounted to 139665 shares of Liquidia Corporation for $1M.

The largest sale of all time was on 2014-09-23 and amounted to 50000 shares of United Therapeutics Corporation for $6.55M.

Biography of JEFFS ROGER

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$575,4444100

Comparison of Insiders on Amount of Buys and Sells

2025-01-14SaleLiquidia Corporation
LQDA
Chief Executive Officer
22,343
0.0271%
$11.78$263,201+30.85%
2024-10-14SaleLiquidia Corporation
LQDA
Chief Executive Officer
8,053
0.0106%
$11.11$89,450+4.98%
2024-07-12SaleLiquidia Corporation
LQDA
Chief Executive Officer
8,053
0.0107%
$12.53$100,904-10.71%
2024-04-12SaleLiquidia Corporation
LQDA
Chief Executive Officer
8,360
0.0115%
$14.58$121,889-14.27%
2024-03-18SaleLiquidia Corporation
LQDA
Chief Executive Officer
28,583
0.0382%
$15.82$452,183-21.63%
2024-03-15SaleAxsome Therapeutics, Inc.
AXSM
director
2,347
0.0047%
$71.61$168,062+15.5%
2024-03-14SaleAxsome Therapeutics, Inc.
AXSM
director
16,976
0.036%
$69.70$1.18M+25.01%
2023-12-14PurchaseLiquidia Corporation
LQDA
Chief Executive Officer
139,665
0.2122%
$7.16$1M+67.76%
2022-09-06PurchaseLiquidia Corporation
LQDA
Chief Executive Officer
43,820
0.0674%
$5.57$243,990+21.89%
2022-08-31PurchaseLiquidia Corporation
LQDA
Chief Executive Officer
993
0.0013%
$4.90$4,870+17.85%
2022-05-24PurchaseLiquidia Corporation
LQDA
Chief Executive Officer
28,000
0.0472%
$3.53$98,812+76.56%
2021-11-19PurchaseAxsome Therapeutics, Inc.
AXSM
director
3,950
0.0109%
$37.30$147,350+3.44%
2021-04-13PurchaseLiquidia Corporation
LQDA
director
198,412
0.3841%
$2.52$499,998+23.24%
2018-09-07PurchaseSangamo Therapeutics, Inc.
SGMO
director
7,408
0.0072%
$13.56$100,487-17.38%
2015-04-28SaleUnited Therapeutics Corporation
UTHR
President & Co-CEO
5,000
0.0108%
$163.31$816,550-6.89%
2015-04-21SaleUnited Therapeutics Corporation
UTHR
President & Co-CEO
10,000
0.0217%
$187.86$1.88M-18.73%
2015-04-14SaleUnited Therapeutics Corporation
UTHR
President & Co-CEO
10,000
0.0217%
$185.82$1.86M-17.33%
2015-04-07SaleUnited Therapeutics Corporation
UTHR
President & Co-CEO
10,000
0.0217%
$179.34$1.79M-14%
2015-03-31SaleUnited Therapeutics Corporation
UTHR
President & Co-CEO
10,000
0.0217%
$172.44$1.72M-10.03%
2015-03-10SaleUnited Therapeutics Corporation
UTHR
President & Co-CEO
8,750
0.0187%
$163.84$1.43M-3.24%
Total: 288
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.